Fny Investment Advisers, LLC Actinium Pharmaceuticals, Inc. Transaction History
Fny Investment Advisers, LLC
- $194 Million
- Q4 2024
A detailed history of Fny Investment Advisers, LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Fny Investment Advisers, LLC holds 23 shares of ATNM stock, worth $26. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23Holding current value
$26% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ATNM
# of Institutions
70Shares Held
7.94MCall Options Held
59.6KPut Options Held
4.8K-
Black Rock Inc. New York, NY1.88MShares$2.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.62MShares$1.89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$804,7880.0% of portfolio
-
State Street Corp Boston, MA621KShares$726,6570.0% of portfolio
-
Acadian Asset Management LLC Boston, MA499KShares$584,1340.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $29.5M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...